Dark

NBIX
Neurocrine Biosciences Inc
stock NASDAQ

Market Open

Aug 26, 2026 12:04:41 PM EDT

154.23USD+0.561%(+0.86)273,045

153.76Bid 162.23Ask 8.47Spread

Pre-market

Aug 25, 2026 8:12:30 AM EDT

158.41USD+3.287%(+5.04)0

After-hours

0.00USD0.000%(0.00)0

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

15.64B

CEO

Kevin Gorman

Headquarters

San Diego, California, USA

Industry

Drug Manufacturers-Specialty & Generic

RGEN ATHX LLY PFE PTN ABBV ANIP CASI PRTK XLV

NBIX Stats

Avg. Vol. 10 Day

1,317,291

Avg. Vol. 30 Day

1,329,552

Employees

470

Market Cap

15,640,789,975

Shares Out.

101,649,181

On/Off Exchange

54%/46%

6 Month Beta

0.52

1 Year Beta

0.64

2 Year Beta

0.81

3 Year Beta

0.70

52 Week Low

122.14

52 Week High

186.12

SMA50

166.62

SMA200

147.21

1 Week

-1.07%

1 Month

-12.78%

3 Month

-1.19%

6 Month

+17.78%

1 Year

+12.45%

2 Year

+1.05%

5 Year

+64.90%

Profile

neurocrine biosciences, inc of san diego is a product based biopharmaceutical company focusing on the development and commercialization of innovative pharmaceutical products to treat unmet medical needs. the company's research and development efforts are focused on neurological and endocrine diseases and disorders. our product candidates address some of the largest pharmaceutical markets in the world including endometriosis, irritable bowel syndrome, anxiety, depression, pain, diabetes, insomnia, and other neurological and endocrine related diseases and disorders

NBIX Stock Summary

Neurocrine Biosciences Inc (NASDAQ:NBIX) stock price today is $154.23, and today's volume is 273,045. NBIX is up 0.561% today. The 30 day average volume is 1,329,552. NBIX market cap is 15.64B with 101,649,181 shares outstanding.